Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 15, 2026

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

Assessing activation states in microglia.

Carol A Colton1, Donna M Wilcock

  • 1Duke University Medical Center, Durham, NC 27710, USA. Carol.Colton@duke.edu

CNS & Neurological Disorders Drug Targets
|March 9, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TNF inhibition differentially impacts regional Abeta immunotherapy efficacy in the humanized hAb<sup>SAA</sup> mouse model.

Alzheimer's research & therapy·2026
Same author

Frequency of mixed neuropathologies in individuals with down syndrome with and without Alzheimer's dementia.

Acta neuropathologica·2026
Same author

Acute anti-Aβ antibody exposure induces microglial changes and significantly alters chemokine signaling.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Role of Cholesterol Metabolism in the Link Between Diabetes and Alzheimer's Disease.

CNS & neurological disorders drug targets·2026
Same journal

Linking Neurodegeneration and Age-related Macular Degeneration: Unified Pathways and Intervention Strategies.

CNS & neurological disorders drug targets·2026
Same journal

Modulating the Microbiota-gut-brain Axis: A Promising Strategy for Alzheimer's Disease Prevention and Management.

CNS & neurological disorders drug targets·2026
Same journal

The Therapeutic Effects of Dietary Supplements on OCD: A Narrative Review.

CNS & neurological disorders drug targets·2026
Same journal

Amyotrophic Lateral Sclerosis: Therapeutic Innovations and Evolving Regulatory Approaches.

CNS & neurological disorders drug targets·2026
Same journal

Pathogenic Proteins Driving ALS Pathogenesis: Molecular Mechanisms and Translational Therapeutic Perspectives.

CNS & neurological disorders drug targets·2026
See all related articles

Microglia, the brain's immune cells, show diverse activation states in neurodegenerative diseases. Understanding these inflammatory responses is key to balancing harmful and resolving factors for disease progression.

Area of Science:

  • Neuroimmunology
  • Neuroinflammation
  • Cellular Biology

Background:

  • Microglia are central to the brain's innate immune response.
  • Microglial activation is increasingly recognized as heterogeneous, impacting disease outcomes.
  • In vitro studies offer insights into acute responses, but in vivo complexities in chronic diseases remain less understood.

Purpose of the Study:

  • To define the functional outcomes of microglial participation in chronic neurodegenerative diseases.
  • To explore the integrated tissue immune response over the extended course of disease.
  • To identify markers of brain inflammatory states and their functional consequences.

Main Methods:

  • Review of existing literature on microglial activation states (classical, alternative, acquired deactivation).

Related Experiment Videos

Last Updated: Jun 15, 2026

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

  • Analysis of cytoactive factors and their expression levels in neuroinflammatory conditions.
  • Discussion of in vivo versus in vitro findings in the context of chronic diseases like Alzheimer's disease.

    • Main Results:

    • Microglial responses are pre-programmed, aiming for pathogen clearance and tissue repair.
    • Chronic neuroinflammation involves complex, regionally varied microglial activation states.
    • Specific markers can indicate brain inflammatory states and their associated functional outcomes.

    Conclusions:

    • A comprehensive understanding of microglial heterogeneity is crucial for neurodegenerative disease research.
    • Identifying markers of inflammation is vital for assessing disease progression.
    • Balancing inflammo-toxic and inflammo-resolution factors is critical for managing chronic neuroinflammatory diseases.